期刊文献+

胰腺癌中内皮抑素表达与微血管密度测定的意义 被引量:4

Expression of endostatin and MVD in pancreatic carcinomas
下载PDF
导出
摘要 目的探讨内皮抑素(endostatin)表达与微血管密度(MVD)在胰腺癌发生、发展中的作用及对预后的影响。方法采用免疫组化SP法检测endostatin、MVD在50例胰腺癌、10例正常胰腺组织中的表达,分析它们与胰腺癌临床病理参数及患者生存率的关系。结果(1)endostatin在正常胰腺组织、胰腺癌中的阳性表达率分别为40%、78%,差异有显著性(P<0.05),其表达强度与胰腺癌临床分期及淋巴结转移相关(P<0.01,P<0.01),与性别、年龄、肿瘤部位、肿瘤直径及分化程度无关。(2)胰腺癌中MVD均值(33.74±11.44),明显高于正常胰腺组织(17.40±4.74)(P<0.01),Ⅲ~Ⅳ期胰腺癌MVD均值(40.89±10.33)高于Ⅰ~Ⅱ期(25.35±5.38)(P<0.01),淋巴结转移组MVD均值(40.84±10.70)高于未转移组(26.64±6.90)(P<0.01),与性别、年龄、肿瘤部位、肿瘤直径及分化程度无关。(3)生存分析提示endostatin及MVD与胰腺癌的预后有关(P<0.01)。结论endostatin及MVD在胰腺癌发展中起重要作用,可对胰腺癌恶性程度的判定和预后评估提供有效的依据。 Purpose To study the effects of the expression of endostatin and MVD on progression and prognosis in pancreatic carcinomas. Methods The expression of endostatin and MVD were studied by S-P immunohistochemistry in 50 cases of pancreatic carcinomas and 10 cases of normal pancreas tissues. Their relationship with clinicopathological features and survival rate was also investigated. Results (1) The expression ratios of endostatin in normal pancreas tissue and in pancreatic carcinoma were 40% and 78% respectively,showing significant difference (P<0.05).The endostatin expression intensity was associated with clinical stages and metastasis of lymph nodes (P<0.01,P<0.01),but was not associated with sex,age,location of tumor,size of tumor and histological grade. (2) The mean MVD in pancreatic carcinomas and in normal tissues was 33.74±11.44 and 17.40±4.74 respectively,showing significant difference(P<0.01).The mean MVD in stage Ⅲ~Ⅳ(40.89±10.33) was much higher than in stageⅠ~Ⅱ(25.35±5.38)(P<0.01),and the mean MVD was higher in those with metastasis of lymph node (40.84±10.70)than those without metastasis(26.64±6.90)(P<0.01),but had no significant difference among sex,age,the location of tumor,size of tumor and histological grade.(3) The analysis of single factor revealed that the expression of endostatin and MVD was significantly related with the prognosis of patients(P<0.01,P<0.01). Conclusions It is suggested that endostatin and MVD play important roles in progression and prognosis of pancreatic carcinoma. Detection of these proteins is useful for diagnosis,prognosis determination and treatment of pancreatic carcinomas.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2005年第3期335-338,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献13

  • 1赵平.我国胰腺癌诊治策略的研究[J].胰腺病学,2002,2(4):193-195. 被引量:19
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer [ J ]. Am J Pathol, 1995,147 ( 1 ) :9 - 19.
  • 4Guenther U, Herbst H, Bauer M, et al. Collagen type X Ⅷ/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas [ J ]. Br J Cancer, 2001,85(10) :1540 -5.
  • 5Feldman AL,Pak H, Yang JC, et al. Serum endostatin levels are elevated in patients with soft tissue sarcoma[ J]. Cancer,2001,91(8) :1525 -9.
  • 6Morimoto T,Aoyagi M,Tamaki M,et al. Increased levels of tissue endostatin in human malignant gliomas [ J ]. Clin Cancer Res,2002,8 ( 9 ) :2933 - 8.
  • 7Hata K, Fujiwaki R, Nakayama K,et al. Expression of the endostatin gene in epithelial ovarian cancer[ J]. Clin Cancer Res,2001,7(8) :2405 -9.
  • 8Feldman AL,Tamarkin L, Paciotti GF,et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage Ⅳ clear cell renal cancer [J]. Clin Cancer Res,2000,6(12) :4628 -34.
  • 9Shaarawy M, El-Sharkawy SA. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer[J]. Acta Oncologic,2001,40(4) :513-8.
  • 10Dhanabal M, Ramchandran R, Waterman MJ, et al. endostatin induces endothelial cell apoptosis [ J ]. J Biol Chem, 1999, 274(17) :11721 -6.

二级参考文献11

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3沈魁主编.胰腺外科.北京:人民卫生出版社,2002,432-471.
  • 4Lundin J, Roberts PJ, Kuusela P, et al. Prognostic singnifica-nce of serum CA242 in pancreatic cancer: a comparison with CA19-9. Anticancer Res, 1995,15:2181-2186.
  • 5Furukawa H, Kousuge T, Mukai K, et al. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma. Arch Surg, 1998, 133:61-65.
  • 6Taylor AM, Roberts SA, Manson JM. Experience with laparoscopic ultrasonography for defining tumour resecta bility in carcinoma of the pancreatic head and periampullary region.Br J Surg, 2001, 88:1077-1083.
  • 7Padillo J, Puente J, Gomez M, et al. Improved cardiac function in patients with obstructive jaundice after in ternal biliary.Ann Surg, 2001, 234:652-656.
  • 8Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreaticoduodenectomty-associated morbidity in 300 consecutive patients. Ann Surg, 2001, 234:47-55.
  • 9Shibata C, Kobari M, Tsuchiya T, et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcimoma in pancreas.World J Surg, 2001, 25:1002-1005.
  • 10Patterson EJ, Gagner M, Salky B, et al. Laparoscopic pancreatic resection: single-institution experience of 19 patients. J Am Coll Surg, 2001, 193:281-287.

共引文献1386

同被引文献32

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部